Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)

被引:152
作者
机构
[1] EFSA, Parma, Italy
关键词
Animal feed; safety; hemp; Cannabis genus; tetrahydrocannabinol (THC); PMTDI;
D O I
10.2903/j.efsa.2011.2011
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Four different types of feed materials derived from the hemp plant were identified: hemp seed, hemp seed meal/cake, hemp seed oil and whole hemp plant (including hemp flour). The hemp varieties allowed for cultivation in Europe need not to exceed 0.2 % THC (in dry matter; average of 2151 samples collected in Europe between 2006 and 2008: 0.075 %). Hemp seeds are practically free of THC (maximum 12 mg THC/kg). The THC lethal dose in acute toxicity studies in rats, mice and dogs is approximately 1000 times higher than the lowest doses known to reproduce typical THC-related symptoms in animals. Both the THC and metabolites with psychoactive properties may be distributed to the different tissues and organs, fat being the target tissue. They are excreted via milk; the transfer rate of oral THC to milk from dairy cows is likely 0.15 %. Studies in humans identified psychotropic effects at a LOEL of 0.04 mg THC/kg bw. By applying an uncertainty factor of 100, a PMTDI of 0.0004 mg/kg bw was derived. Since the PMTDI is based on acute pharmacological effects, the consumer exposure considered the single high consumption record derived from the EFSA Comprehensive European Food Consumption Database (P95 values of consumers only: 2 L milk equivalents for adults, 1.5 L for children). In all scenarios (varying intake of hemp plant derived feed material and milk yields), consumer exposure to THC was considerably above the PMTDI for adults and for children; applying the same exposure calculations to hemp seed-derived feed materials results were below the PMTDI. The FEEDAP Panel recommended to put whole hemp plant-derived feed materials list of materials whose placing on the market or use for animal nutritional purposes is restricted or prohibited and to introduce a maximum THC content of 10 mg/kg to hemp seed-derived feed materials. (C) European Food Safety Authority, 2011
引用
收藏
页数:41
相关论文
共 103 条
  • [1] PASSIVE CONSUMPTION OF MARIJUANA THROUGH MILK - A LOW-LEVEL CHRONIC EXPOSURE TO DELTA-9-TETRAHYDROCANNABINOL (THC)
    AHMAD, GR
    AHMAD, N
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1990, 28 (02): : 255 - 260
  • [2] Cannabinoids in the treatment of cancer
    Alexander, Amy
    Smith, Paul F.
    Rosengren, Rhonda J.
    [J]. CANCER LETTERS, 2009, 285 (01) : 6 - 12
  • [3] Pharmacology and effects of cannabis: a brief review
    Ashton, CH
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 : 101 - 106
  • [4] MATERNAL MARIJUANA USE DURING LACTATION AND INFANT DEVELOPMENT AT ONE YEAR
    ASTLEY, SJ
    LITTLE, RE
    [J]. NEUROTOXICOLOGY AND TERATOLOGY, 1990, 12 (02) : 161 - 168
  • [5] DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS
    BEAL, JE
    OLSON, R
    LAUBENSTEIN, L
    MORALES, JO
    BELLMAN, P
    YANGCO, B
    LEFKOWITZ, L
    PLASSE, TF
    SHEPARD, KV
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) : 89 - 97
  • [6] Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
    Beal, JE
    Olson, R
    Lefkowitz, L
    Larenstein, L
    Bellman, P
    Yangco, B
    Morales, JO
    Murphy, R
    Powderly, W
    Plasse, TF
    Mosdell, KW
    Shepard, KV
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (01) : 7 - 14
  • [7] METABOLIC AND PSYCHOPHYSIOLOGIC STUDIES OF CANNABIDIOL-HEXOBARBITAL INTERACTION
    BENOWITZ, NL
    NGUYEN, TL
    JONES, RT
    HERNING, RI
    BACHMAN, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (01) : 115 - 120
  • [8] Bischoff K, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P391, DOI 10.1016/B978-012370467-2/50121-8
  • [9] CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: Kinetics, pharmacogenetics and interaction with phenytoin
    Bland, TM
    Haining, RL
    Tracy, TS
    Callery, PS
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 70 (07) : 1096 - 1103
  • [10] Characterization of cytochrome P450 3A inactivation by cannabidiol: Possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator
    Bornheim, LM
    Grillo, MP
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (10) : 1209 - 1216